Advertisement
Screener

Amgen Inc. (AMGN) Executive Pay versus Performance: Performance Measures

Amgen Inc. Most Important Performance Measures

The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.

  • 2023-04-06: Measure Non-GAAP earnings per share (EPS).
  • 2023-04-06: Measure Non-GAAP return on invested capital (ROIC).
  • 2023-04-06: Measure Total shareholder return (TSR) relative to that of the S&P 500.
  • 2023-04-06: Measure Revenues.
Proxy filedMeasure
2023-04-06Non-GAAP earnings per share (EPS)
2023-04-06Non-GAAP return on invested capital (ROIC)
2023-04-06Total shareholder return (TSR) relative to that of the S&P 500
2023-04-06Revenues
2023-04-06Non-GAAP net income
2023-04-06Pipeline, clinical study, and regulatory goals
2023-04-06Environmental, social, and governance goals
2024-04-17Non-GAAP earnings per share (EPS)
2024-04-17Non-GAAP return on invested capital (ROIC)
2024-04-17Total shareholder return (TSR) relative to that of the S&P 500
2024-04-17Revenues
2024-04-17Non-GAAP net income
2024-04-17Pipeline, clinical study, and regulatory goals
2024-04-17Environmental, social, and governance goals
2025-04-09Non-GAAP earnings per share (EPS)
2025-04-09Non-GAAP return on invested capital (ROIC)
2025-04-09Total shareholder return (TSR) relative to that of the S&P 500
2025-04-09Revenues
2025-04-09Non-GAAP net income
2025-04-09Pipeline, clinical study, and regulatory goals
2025-04-09Sustainability and integration goals
2026-04-07Non-GAAP earnings per share (EPS)
2026-04-07Non-GAAP return on invested capital (ROIC)
2026-04-07Total shareholder return (TSR) relative to that of the S&P 500
2026-04-07Revenues
2026-04-07Non-GAAP net income
2026-04-07Pipeline, clinical study, and regulatory goals
2026-04-07Workforce and technology goals

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31